Patents by Inventor Annelies Coddens

Annelies Coddens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVED IMMUNOGENICITY ASSAYS
    Publication number: 20220099682
    Abstract: The present invention relates to improved immunogenicity assays and methods for performing the same. In particular, the present invention relates to improved immunogenicity assays that are capable of distinguishing neutralizing anti-drug antibodies from non-neutralizing anti-drug antibodies. More in particular, the present invention relates to improved immunogenicity assays that allow (amounts and/or concentrations of) neutralizing anti-drug antibodies to be detected and/or measured in a sample even in the presence of non-neutralizing anti-drug antibodies.
    Type: Application
    Filed: March 29, 2018
    Publication date: March 31, 2022
    Applicant: Ablynx N.V.
    Inventors: Annelies Coddens, Veerle Snoeck, Marie-Ange Buyse, Carlo Boutton
  • IMPROVED IMMUNOGENICITY ASSAYS
    Publication number: 20210239709
    Abstract: The present invention relates to improved immunogenicity assays and methods for performing the same. In particular, the present invention relates to improved immunogenicity assays that are capable of distinguishing neutralizing anti-drug antibodies from non-neutralizing anti-drug antibodies. More in particular, the present invention relates to improved immunogenicity assays that allow (amounts and/or concentrations of) neutralizing anti-drug antibodies to be detected and/or measured in a sample even in the presence of non-neutralizing anti-drug antibodies.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 5, 2021
    Applicant: Ablynx N.V.
    Inventors: Annelies Coddens, Veerle Snoeck, Marie-Ange Buyse, Carlo Boutton
  • Inhibitors of F18+ binding
    Patent number: 8703722
    Abstract: The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18+ E. coli infections in pigs and in screening methods.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: April 22, 2014
    Assignee: Universiteit Gent
    Inventors: Annelies Coddens, Eric Cox, Susann Eva Teneberg
  • INHIBITORS OF F18+ E COLI BINDING
    Publication number: 20110306574
    Abstract: The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18? E. coli infections in pigs and in screening methods.
    Type: Application
    Filed: September 30, 2009
    Publication date: December 15, 2011
    Applicant: GHENT UNIVERSITY
    Inventors: Annelies Coddens, Eric Cox, Susann Eva Teneberg